Proteomics and metabolomics delve into the dynamic functional layers of biological systems, offering critical insights beyond genomic information. Proteomics focuses on large-scale analysis of protein expression, structure, interactions, and post-translational modifications, shedding light on cellular behavior and disease mechanisms. Metabolomics, on the other hand, profiles the complete set of small-molecule metabolites within a biological system, providing a snapshot of physiological states and metabolic changes in real time. These disciplines are instrumental in biomarker discovery, drug development, systems biology, and personalized medicine. Advanced tools such as mass spectrometry, NMR spectroscopy, and bioinformatics platforms are essential in navigating the complexity of biological networks. Proteomics and metabolomics collectively contribute to understanding disease progression, optimizing therapeutics, and predicting treatment outcomes with unparalleled precision.
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Advancement in dual lateral flow immunoassay design for sensitive, rapid detection of rotavirus and adenovirus in stool samples
Ayan Ahmed Isse, Genexus Biotech Company, Somalia
Title :
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Diversity analyses of microbial communities in Armanis gold-polymetallic mine and acid mine drainage: Bioremediation
Anna Khachatryan, SPC Armbiotechnology of NAS of Armenia, Armenia